Abeona Therapeutics (ABEO) revenue breakdown
By product, License is the largest at 58% of fiscal 2025 revenue, growing 138% a year over 2 years.
Revenue by product
Fiscal years, as Abeona Therapeutics reports them in its 10-K filings; fiscal 2025 total $6M.
| Products | 2016 | 2017 | 2018 | 2025 | Share |
|---|---|---|---|---|---|
| License | — | $602,000 | — | $3M | 58% |
| Product | — | — | — | $2M | 42% |
| Foundation Revenues | — | — | $3M | — | — |
| License revenues | $602,000 | — | — | — | — |
| Royalties | $287,000 | $235,000 | $202,000 | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ABEO.
Open ABEO in InvestinglyQuestions
Where does Abeona Therapeutics make its money?
In fiscal 2025, by product: License $3M, Product $2M.
From Abeona Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.